CUE Insider Trading

Insider Ownership Percentage: 7.49%
Insider Buying (Last 12 Months): $19,620.00
Insider Selling (Last 12 Months): $0.00

Cue Biopharma Insider Trading History Chart

This chart shows the insider buying and selling history at Cue Biopharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cue Biopharma Share Price & Price History

Current Price: $1.74
Price Change: Price Decrease of -0.17 (-8.90%)
As of 05/23/2024 01:00 AM ET

This chart shows the closing price history over time for CUE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Cue Biopharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/25/2023Anish SuriInsiderBuy4,000$2.76$11,040.00135,638View SEC Filing Icon  
8/14/2023Daniel R. PasseriCEOBuy3,000$2.86$8,580.00134,578View SEC Filing Icon  
3/23/2023Peter A KienerDirectorSell9,325$3.28$30,586.00357View SEC Filing Icon  
5/23/2022Aaron G.L. FletcherDirectorBuy150,000$3.52$528,000.00885,000View SEC Filing Icon  
3/31/2022Aaron G.L. FletcherDirectorBuy735,000$4.76$3,498,600.00165,000View SEC Filing Icon  
10/1/2021Kerri-Ann MillarCFOSell1,251$14.21$17,776.71View SEC Filing Icon  
9/24/2021Daniel R. PasseriCEOBuy3,400$14.72$50,048.00View SEC Filing Icon  
9/23/2021Anish SuriInsiderSell20,000$15.23$304,600.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Cue Biopharma (NASDAQ:CUE)

35.04% of Cue Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CUE by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Cue Biopharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2024Carlson Capital L P20,000$38K0.0%-83.3%0.041%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.2,283,362$4.32M0.0%+7.1%4.694%Search for SEC Filing on Google Icon
5/9/2024Monaco Asset Management SAM334,742$0.63M0.2%-2.2%0.688%Search for SEC Filing on Google Icon
4/10/2024Wedmont Private Capital40,000$76K0.0%+100.0%0.082%Search for SEC Filing on Google Icon
2/8/2024Legacy Capital Group California Inc.10,000$26K0.0%N/A0.022%Search for SEC Filing on Google Icon
2/7/2024Monaco Asset Management SAM342,242$0.90M0.3%-4.9%0.759%Search for SEC Filing on Google Icon
2/1/2024Sigma Planning Corp108,875$0.29M0.0%-55.5%0.241%Search for SEC Filing on Google Icon
1/18/2024Navalign LLC25,000$66K0.0%N/A0.055%Search for SEC Filing on Google Icon
1/18/2024Good Life Advisors LLC100,000$0.26M0.0%-10.7%0.222%Search for SEC Filing on Google Icon
11/7/2023Monaco Asset Management SAM359,739$0.83M0.2%-2.9%0.800%Search for SEC Filing on Google Icon
11/7/2023New York State Common Retirement Fund11,984$28K0.0%-53.4%0.027%Search for SEC Filing on Google Icon
11/6/2023Sigma Planning Corp244,705$0.56M0.0%+8.6%0.544%Search for SEC Filing on Google Icon
10/24/2023Channel Wealth LLC15,300$35K0.0%-77.7%0.034%Search for SEC Filing on Google Icon
10/13/2023Sanders Morris Harris LLC346,212$0.80M0.2%+513.6%0.770%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC12,946$48K0.0%+114.7%0.029%Search for SEC Filing on Google Icon
8/15/2023Silverarc Capital Management LLC403,402$1.47M0.5%+31.7%0.897%Search for SEC Filing on Google Icon
8/10/2023Carlson Capital L P134,036$0.49M0.0%-47.2%0.310%Search for SEC Filing on Google Icon
8/8/2023Monaco Asset Management SAM370,407$1.35M0.4%-20.6%0.858%Search for SEC Filing on Google Icon
8/4/2023American International Group Inc.16,635$61K0.0%N/A0.039%Search for SEC Filing on Google Icon
8/2/2023Sigma Planning Corp225,300$0.82M0.0%+2.0%0.522%Search for SEC Filing on Google Icon
7/27/2023Virtu Financial LLC17,594$64K0.0%N/A0.041%Search for SEC Filing on Google Icon
7/26/2023Channel Wealth LLC68,700$0.25M0.1%+14.4%0.159%Search for SEC Filing on Google Icon
7/13/2023Cambridge Investment Research Advisors Inc.20,000$73K0.0%N/A0.046%Search for SEC Filing on Google Icon
7/11/2023Sanders Morris Harris LLC56,420$0.20M0.0%N/A0.131%Search for SEC Filing on Google Icon
5/12/2023Prosight Management LP1,151,855$4.11M1.9%-37.4%2.668%Search for SEC Filing on Google Icon
5/8/2023Sigma Planning Corp220,889$0.79M0.0%+14.6%0.512%Search for SEC Filing on Google Icon
5/1/2023P.A.W. Capital Corp150,000$0.54M1.2%-16.7%0.347%Search for SEC Filing on Google Icon
4/27/2023Channel Wealth LLC60,050$0.21M0.1%N/A0.139%Search for SEC Filing on Google Icon
4/18/2023ETF Managers Group LLC13,528$48K0.0%N/A0.031%Search for SEC Filing on Google Icon
2/13/2023Voss Capital LLC125,000$0.36M0.1%-37.5%0.290%Search for SEC Filing on Google Icon
2/13/2023GSA Capital Partners LLP188,308$0.54M0.1%-12.9%0.438%Search for SEC Filing on Google Icon
2/10/2023Good Life Advisors LLC75,000$0.21M0.0%+31.6%0.174%Search for SEC Filing on Google Icon
2/10/2023Connor Clark & Lunn Investment Management Ltd.22,970$65K0.0%-29.7%0.053%Search for SEC Filing on Google Icon
2/3/2023Monaco Asset Management SAM497,177$1.42M0.4%+8.4%1.155%Search for SEC Filing on Google Icon
2/1/2023Bank of Montreal Can33,900$98K0.0%N/A0.079%Search for SEC Filing on Google Icon
1/31/2023Monaco Asset Management SAM497,177$1.42M0.4%+8.4%1.155%Search for SEC Filing on Google Icon
1/24/2023Sigma Planning Corp192,734$0.55M0.0%+2.3%0.448%Search for SEC Filing on Google Icon
1/13/2023Sanders Morris Harris LLC56,420$0.16M0.1%-93.3%0.131%Search for SEC Filing on Google Icon
11/15/2022Prosight Management LP1,545,573$3.45M1.8%-6.6%4.368%Search for SEC Filing on Google Icon
11/15/2022Carlson Capital L P535,000$1.19M0.1%-7.8%1.512%Search for SEC Filing on Google Icon
11/14/2022Annandale Capital LLC65,000$0.15M0.1%N/A0.184%Search for SEC Filing on Google Icon
11/14/2022Ergoteles LLC117,074$0.26M0.0%-14.2%0.331%Search for SEC Filing on Google Icon
11/10/2022Sigma Planning Corp188,424$0.42M0.0%+12.8%0.533%Search for SEC Filing on Google Icon
11/10/2022Nantahala Capital Management LLC93,297$0.21M0.0%-7.1%0.264%Search for SEC Filing on Google Icon
11/10/2022Connor Clark & Lunn Investment Management Ltd.32,677$73K0.0%N/A0.092%Search for SEC Filing on Google Icon
11/2/2022Voss Capital LLC200,000$0.45M0.1%+100.0%0.565%Search for SEC Filing on Google Icon
11/1/2022P.A.W. Capital Corp200,000$0.45M0.7%+14.3%0.565%Search for SEC Filing on Google Icon
10/31/2022Monaco Asset Management SAM458,851$1.02M0.4%+3.4%1.297%Search for SEC Filing on Google Icon
10/13/2022Newbridge Financial Services Group Inc.17,000$38K0.0%+41.7%0.048%Search for SEC Filing on Google Icon
10/7/2022Sanders Morris Harris LLC848,048$2.02M0.5%+15.2%2.397%Search for SEC Filing on Google Icon
8/16/2022Delphia USA Inc.10,126$25K0.0%N/A0.029%Search for SEC Filing on Google Icon
8/15/2022Nantahala Capital Management LLC100,464$0.25M0.0%-95.5%0.284%Search for SEC Filing on Google Icon
8/13/2022Voss Capital LLC100,000$0.25M0.1%N/A0.283%Search for SEC Filing on Google Icon
8/13/2022Prosight Management LP1,655,477$4.12M3.2%+9.6%4.679%Search for SEC Filing on Google Icon
8/12/2022Ensign Peak Advisors Inc17,960$45K0.0%+72.7%0.051%Search for SEC Filing on Google Icon
8/11/2022Sigma Planning Corp167,106$0.42M0.0%+28.8%0.472%Search for SEC Filing on Google Icon
8/1/2022Monaco Asset Management SAM443,851$1.11M0.5%+886.3%1.255%Search for SEC Filing on Google Icon
7/19/2022Good Life Advisors LLC57,000$0.14M0.0%N/A0.161%Search for SEC Filing on Google Icon
7/15/2022Newbridge Financial Services Group Inc.12,000$30K0.0%+200.0%0.034%Search for SEC Filing on Google Icon
7/13/2022P.A.W. Capital Corp175,000$0.44M0.6%+16.7%0.495%Search for SEC Filing on Google Icon
7/11/2022Sanders Morris Harris LLC736,212$1.80M0.4%-15.7%2.081%Search for SEC Filing on Google Icon
6/30/2022Amalgamated Bank5,025$25K0.0%N/A0.014%Search for SEC Filing on Google Icon
5/17/2022Prosight Management LP1,510,282$7.37M4.8%+82.2%4.270%Search for SEC Filing on Google Icon
5/11/2022Bleichroeder LP552,000$2.69M0.5%+176.0%1.672%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP96,563$0.47M0.1%-3.3%0.293%Search for SEC Filing on Google Icon
5/9/2022WealthShield Partners LLC29,951$0.15M0.0%+161.7%0.091%Search for SEC Filing on Google Icon
5/9/2022Monaco Asset Management SAM45,000$0.22M0.1%N/A0.136%Search for SEC Filing on Google Icon
5/4/2022Advisor Group Holdings Inc.38,182$2.41M0.0%+43.4%0.116%Search for SEC Filing on Google Icon
4/21/2022Virginia Retirement Systems ET AL11,000$54K0.0%-31.3%0.033%Search for SEC Filing on Google Icon
4/21/2022P.A.W. Capital Corp150,000$0.73M0.8%+25.0%0.454%Search for SEC Filing on Google Icon
4/20/2022Sigma Planning Corp129,728$0.63M0.0%+51.0%0.393%Search for SEC Filing on Google Icon
4/11/2022Sanders Morris Harris LLC873,021$4.26M0.8%+143.1%2.645%Search for SEC Filing on Google Icon
2/14/2022GSA Capital Partners LLP99,816$1.13M0.1%-18.0%0.314%Search for SEC Filing on Google Icon
2/11/2022Granite Point Capital Management L.P.110,000$1.24M0.2%N/A0.346%Search for SEC Filing on Google Icon
2/11/2022Ensign Peak Advisors Inc10,400$0.12M0.0%N/A0.033%Search for SEC Filing on Google Icon
2/10/2022Bleichroeder LP200,000$2.26M0.4%+14.3%0.630%Search for SEC Filing on Google Icon
2/10/2022Rafferty Asset Management LLC97,062$1.10M0.0%+148.8%0.306%Search for SEC Filing on Google Icon
2/10/2022WealthShield Partners LLC11,444$0.13M0.0%-38.5%0.036%Search for SEC Filing on Google Icon
2/10/2022Citigroup Inc.80,185$0.91M0.0%+184.3%0.252%Search for SEC Filing on Google Icon
2/10/2022P.A.W. Capital Corp120,000$1.36M1.2%-4.0%0.378%Search for SEC Filing on Google Icon
2/9/2022BNP Paribas Arbitrage SA21,294$0.24M0.0%+277.9%0.067%Search for SEC Filing on Google Icon
2/9/2022Dimensional Fund Advisors LP849,343$9.61M0.0%+360.1%2.674%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp316,467$3.58M0.0%+2.2%0.996%Search for SEC Filing on Google Icon
2/3/2022Advisor Group Holdings Inc.26,620$0.30M0.0%-14.7%0.084%Search for SEC Filing on Google Icon
2/3/2022Virginia Retirement Systems ET AL16,000$0.18M0.0%+29.0%0.050%Search for SEC Filing on Google Icon
2/2/2022Sanders Morris Harris LLC359,113$4.42M0.8%+17.5%1.131%Search for SEC Filing on Google Icon
2/2/2022Sigma Planning Corp85,893$0.97M0.0%+2.0%0.270%Search for SEC Filing on Google Icon
1/25/2022Belvedere Trading LLC19,819$0.18M0.0%N/A0.062%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Advisers LP202,000$2.94M0.0%-32.2%0.636%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Investments LP103,430$1.51M0.0%-48.5%0.326%Search for SEC Filing on Google Icon
11/15/2021California State Teachers Retirement System39,229$0.57M0.0%-4.5%0.124%Search for SEC Filing on Google Icon
11/15/2021Marshall Wace LLP26,340$0.38M0.0%-16.8%0.083%Search for SEC Filing on Google Icon
11/15/2021683 Capital Management LLC743,772$10.84M0.4%+5.6%2.342%Search for SEC Filing on Google Icon
11/15/2021Virtus ETF Advisers LLC15,636$0.23M0.1%-4.9%0.049%Search for SEC Filing on Google Icon
11/15/2021Dimensional Fund Advisors LP184,612$2.69M0.0%+128.7%0.581%Search for SEC Filing on Google Icon
11/15/2021GSA Capital Partners LLP121,727$1.77M0.2%+328.7%0.383%Search for SEC Filing on Google Icon
11/12/2021Carlson Capital L P102,816$1.50M0.1%-31.8%0.326%Search for SEC Filing on Google Icon
11/12/2021Prosight Management LP655,185$9.55M5.3%+3.9%2.079%Search for SEC Filing on Google Icon
11/12/2021WealthShield Partners LLC18,621$0.27M0.1%+76.8%0.059%Search for SEC Filing on Google Icon
11/12/2021Macquarie Group Ltd.8,016$0.12M0.0%+1,164.4%0.025%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Cue Biopharma logo
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops a novel class of injectable therapeutics to selectively engage and modulate targeted, disease relevant T cells directly within the patient's body. Its lead drug product candidate is CUE-101 for the treatment of human papilloma virus (HPV16+)-driven recurrent/metastatic head and neck cancer. The company is also developing CUE-102 targets Wilms' Tumor 1 protein in various cancers; CUE-103, a CUE-100 series drug product candidate; and Neo-STAT and RDI-STAT programs outside of oncology, including CUE-200, CUE-300, and CUE-400 series. It has collaboration agreements with LG Chem, Ltd. for the development of Immuno-STATs focused in the field of oncology; strategic collaboration and option agreement with Ono Pharmaceutical Co., Ltd. to advance CUE-401 for the treatment of autoimmune and inflammatory diseases; and license agreement with Albert Einstein College of Medicine. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.
Read More on Cue Biopharma

Today's Range

Now: $1.74
Low: $1.70
High: $1.94

50 Day Range

MA: $1.79
Low: $1.37
High: $2.18

52 Week Range

Now: $1.74
Low: $1.30
High: $4.89

Volume

160,124 shs

Average Volume

280,767 shs

Market Capitalization

$84.63 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.98

Who are the company insiders with the largest holdings of Cue Biopharma?

Cue Biopharma's top insider investors include:
  1. Aaron GL Fletcher (Director)
  2. Anish Suri (Insider)
  3. Daniel R Passeri (CEO)
  4. Peter A Kiener (Director)
Learn More about top insider investors at Cue Biopharma.

Who are the major institutional investors of Cue Biopharma?

Cue Biopharma's top institutional investors include:
  1. Vanguard Group Inc. — 4.69%
  2. Monaco Asset Management SAM — 0.69%
  3. Wedmont Private Capital — 0.08%
  4. Carlson Capital L P — 0.04%
  5. Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Cue Biopharma stock.

Which institutional investors are selling Cue Biopharma stock?

During the previous quarter, CUE stock was sold by these institutional investors:
  1. Carlson Capital L P
  2. Monaco Asset Management SAM

Which institutional investors are buying Cue Biopharma stock?

During the last quarter, CUE stock was acquired by institutional investors including:
  1. Vanguard Group Inc.
  2. Wedmont Private Capital
During the previous year, these company insiders have bought Cue Biopharma stock:
  1. Aaron GL Fletcher (Director)
  2. Anish Suri (Insider)
  3. Daniel R Passeri (CEO)
Learn More investors buying Cue Biopharma stock.